Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Adenocarcinoma
High-resolution genomic profiles of human lung cancer.
Adenocarcinoma
PPAPDC1B and WHSC1L1 Are Common Drivers of the 8p11-12 Amplicon, Not Only in Breast Tumors But also in Pancreatic Adenocarcinomas and Lung Tumors.
Adenocarcinoma
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Bone Diseases
Insulin like growth factor binding protein 7 (IGFBP7) expression is linked to poor prognosis but may protect from bone disease in multiple myeloma.
Breast Neoplasms
Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ER? in SUM-44 breast cancer cells and is associated with ER? over-expression in breast cancer.
Breast Neoplasms
An epigenomic approach to therapy for tamoxifen-resistant breast cancer.
Breast Neoplasms
Downregulation of MMSET impairs breast cancer proliferation and metastasis through inhibiting Wnt/?-catenin signaling.
Breast Neoplasms
EZH2 and MMSET Were Identified as Potentially Useful Therapeutic Targets in Metaplastic Breast Carcinoma.
Breast Neoplasms
High WHSC1L1 Expression Reduces Survival Rates in Operated Breast Cancer Patients with Decreased CD8+ T Cells: Machine Learning Approach.
Breast Neoplasms
Metnase mediates resistance to topoisomerase II inhibitors in breast cancer cells.
Breast Neoplasms
PPAPDC1B and WHSC1L1 Are Common Drivers of the 8p11-12 Amplicon, Not Only in Breast Tumors But also in Pancreatic Adenocarcinomas and Lung Tumors.
Breast Neoplasms
Transforming properties of 8p11-12 amplified genes in human breast cancer.
Breast Neoplasms
WHSC1 promotes wnt/?-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
Carcinogenesis
Characterization of the EZH2-MMSET histone methyltransferase regulatory axis in cancer.
Carcinogenesis
Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
Carcinogenesis
High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
Carcinogenesis
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
Carcinogenesis
Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2.
Carcinogenesis
Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
Carcinogenesis
MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells.
Carcinogenesis
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Carcinogenesis
The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
Carcinogenesis
WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.
Carcinoma
Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway.
Carcinoma
Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
Carcinoma
Overexpression of multiple myeloma SET domain (MMSET) is associated with advanced tumor aggressiveness and poor prognosis in serous ovarian carcinoma.
Carcinoma
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Carcinoma
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Carcinoma
The histone methyltransferase WHSC1 is regulated by EZH2 and is important for ovarian clear cell carcinoma cell proliferation.
Carcinoma
The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
Carcinoma
WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck.
Carcinoma
WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.
Carcinoma
WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.
Carcinoma, Adenoid Cystic
Knockdown of Histone Methyltransferase WHSC1 Induces Apoptosis and Inhibits Cell Proliferation and Tumorigenesis in Salivary Adenoid Cystic Carcinoma.
Carcinoma, Hepatocellular
Overexpression of MMSET is Correlation with Poor Prognosis in Hepatocellular Carcinoma.
Carcinoma, Hepatocellular
WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.
Carcinoma, Non-Small-Cell Lung
CircRNA WHSC1 promotes non-small cell lung cancer progression via sponging microRNA-296-3p and up-regulating expression of AKT serine/threonine kinase 3.
Carcinoma, Squamous Cell
Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway.
Carcinoma, Squamous Cell
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Carcinoma, Squamous Cell
WHSC1 monomethylates histone H1 and induces stem-cell like features in squamous cell carcinoma of the head and neck.
Carcinoma, Squamous Cell
WHSC1 promotes oncogenesis through regulation of NIMA-related kinase-7 in squamous cell carcinoma of the head and neck.
Carcinoma, Squamous Cell
WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.
Chagas Disease
Antiproliferative effects of delta 24(25) sterol methyl transferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.
Chondroblastoma
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas.
Cleft Palate
Retinoic acid inhibits histone methyltransferase Whsc1 during palatogenesis.
Colonic Neoplasms
Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2.
Colonic Neoplasms
Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis.
Colonic Neoplasms
Potential role for the Metnase transposase fusion gene in colon cancer through the regulation of key genes.
Colonic Neoplasms
Study of the interaction among Notch pathway receptors, correlation with stemness, as well as their interaction with CD44, dipeptidyl peptidase-IV, hepatocyte growth factor receptor and the SETMAR transferase, in colon cancer stem cells.
Colonic Neoplasms
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Colorectal Neoplasms
Histone methyltransferase WHSC1 inhibits colorectal cancer cell apoptosis via targeting anti-apoptotic BCL2.
Dementia
Comparison of in-person and telephone administration of the Mini-Mental State Examination in the University of Alabama at Birmingham Study of Aging.
Dwarfism
H3K36 methylation is critical for brassinosteroid-regulated plant growth and development in rice.
Endometrial Neoplasms
CircRNA WHSC1 targets the miR-646/NPM1 pathway to promote the development of endometrial cancer.
Endometrial Neoplasms
miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.
Endometrial Neoplasms
Overexpression of MMSET in endometrial cancer: A clinicopathologic study.
Glioblastoma
MMSET is overexpressed in cancers: link with tumor aggressiveness.
Glioma
Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas.
Head and Neck Neoplasms
WHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.
Heart Defects, Congenital
Epigenetic mechanisms in cardiac development and disease.
Hematologic Neoplasms
SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Hypersensitivity
Metnase promotes restart and repair of stalled and collapsed replication forks.
Infections
Expression levels of the human DNA repair protein metnase influence lentiviral genomic integration.
Infections
Genome-wide DNA methylation analysis during non-alcoholic steatohepatitis-related multistage hepatocarcinogenesis: comparison with hepatitis virus-related carcinogenesis.
Infections
Optimal ratio of transcription factors for somatic cell reprogramming.
Infertility
Evaluation of polymorphisms in predicted target sites for micro-RNAs differentially expressed in endometriosis.
Intellectual Disability
De novo nonsense mutation in WHSC1 (NSD2) in patient with intellectual disability and dysmorphic features.
Intellectual Disability
Dissecting the Wolf-Hirschhorn syndrome phenotype: WHSC1 is a neurodevelopmental gene contributing to growth delay, intellectual disability, and to the facial dysmorphism.
Intellectual Disability
Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.
Kidney Neoplasms
Variation in chromatin accessibility in human kidney cancer links H3K36 methyltransferase loss with widespread RNA processing defects.
Language Development Disorders
Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn syndrome.
Leukemia
Metnase mediates chromosome decatenation in acute leukemia cells.
Leukemia
Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
Leukemia
The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.
Leukemia, Myeloid, Acute
Metnase mediates chromosome decatenation in acute leukemia cells.
Leukemia, Myeloid, Acute
The enigma of ectopic expression of FGFR3 in multiple myeloma: a critical initiating event or just a target for mutational activation during tumor progression.
Liver Neoplasms
The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
Lung Neoplasms
CircRNA WHSC1 promotes non-small cell lung cancer progression via sponging microRNA-296-3p and up-regulating expression of AKT serine/threonine kinase 3.
Lung Neoplasms
Fragment-based discovery of a chemical probe for the PWWP1 domain of NSD3.
Lung Neoplasms
High-resolution genomic profiles of human lung cancer.
Lung Neoplasms
Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
Lung Neoplasms
PPAPDC1B and WHSC1L1 Are Common Drivers of the 8p11-12 Amplicon, Not Only in Breast Tumors But also in Pancreatic Adenocarcinomas and Lung Tumors.
Lymphatic Metastasis
Overexpression of MMSET in endometrial cancer: A clinicopathologic study.
Lymphoma
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
Lymphoma, Mantle-Cell
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.
Microcephaly
109?kb deletion of chromosome 4p16.3 in a patient with mild phenotype of Wolf-Hirschhorn syndrome.
Microcephaly
Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2).
Multiple Myeloma
"Snorkeling" for missing players in cancer.
Multiple Myeloma
A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.
Multiple Myeloma
A Scalable Platform for Producing Recombinant Nucleosomes with Codified Histone Methyltransferase Substrate Preferences.
Multiple Myeloma
Correlation of TACC3, FGFR3, MMSET and p21 expression with the t(4;14)(p16.3;q32) in multiple myeloma.
Multiple Myeloma
Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms.
Multiple Myeloma
FGFR3 dysregulation in multiple myeloma: frequency and prognostic relevance.
Multiple Myeloma
H3K36 dimethylation by MMSET promotes classical non-homologous end-joining at unprotected telomeres.
Multiple Myeloma
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
Multiple Myeloma
Hypoxia-induced CREB cooperates MMSET to modify chromatin and promote DKK1 expression in multiple myeloma.
Multiple Myeloma
Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
Multiple Myeloma
Impact of genes highly correlated with MMSET myeloma on survival of Non-MMSET myeloma patients.
Multiple Myeloma
In multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.
Multiple Myeloma
MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis.
Multiple Myeloma
Metformin elicits antitumor effects and downregulates the histone methyltransferase multiple myeloma SET domain (MMSET) in prostate cancer cells.
Multiple Myeloma
MMSET deregulation affects cell cycle progression and adhesion regulons in t(4;14) myeloma plasma cells.
Multiple Myeloma
MMSET I acts as an oncoprotein and regulates GLO1 expression in t(4;14) multiple myeloma cells.
Multiple Myeloma
MMSET is highly expressed and associated with aggressiveness in neuroblastoma.
Multiple Myeloma
MMSET is overexpressed in cancers: link with tumor aggressiveness.
Multiple Myeloma
MMSET: role and therapeutic opportunities in multiple myeloma.
Multiple Myeloma
Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis.
Multiple Myeloma
Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.
Multiple Myeloma
NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.
Multiple Myeloma
Nucleosome Binding Alters the Substrate Bonding Environment of Histone H3 Lysine 36 Methyltransferase NSD2.
Multiple Myeloma
Overexpression of MMSET is Correlation with Poor Prognosis in Hepatocellular Carcinoma.
Multiple Myeloma
Overexpression of transcripts originating from the MMSET locus characterizes all t(4;14)(p16;q32)-positive multiple myeloma patients.
Multiple Myeloma
Plasma membrane proteomics identifies biomarkers associated with MMSET overexpression in T(4;14) multiple myeloma.
Multiple Myeloma
Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074.
Multiple Myeloma
The enigma of ectopic expression of FGFR3 in multiple myeloma: a critical initiating event or just a target for mutational activation during tumor progression.
Multiple Myeloma
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Multiple Myeloma
The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.
Multiple Myeloma
The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.
Multiple Myeloma
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
Multiple Myeloma
Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma.
Multiple Myeloma
Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression.
Multiple Myeloma
WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma.
Myelodysplastic Syndromes
SETD2 deficiency accelerates MDS-associated leukemogenesis via S100a9 in NHD13 mice and predicts poor prognosis in MDS.
Neoplasm Metastasis
AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Neoplasm Metastasis
Downregulation of MMSET impairs breast cancer proliferation and metastasis through inhibiting Wnt/?-catenin signaling.
Neoplasm Metastasis
MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.
Neoplasm Metastasis
miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.
Neoplasm Metastasis
Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis.
Neoplasm Metastasis
Overexpression of MMSET in endometrial cancer: A clinicopathologic study.
Neoplasm Metastasis
Re: AKT-Mediated Stabilization of Histone Methyltransferase WHSC1 Promotes Prostate Cancer Metastasis.
Neoplasm Metastasis
WHSC1 promotes wnt/?-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
Neoplasms
A high-risk signature for patients with multiple myeloma established from the molecular classification of human myeloma cell lines.
Neoplasms
AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Neoplasms
Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ER? in SUM-44 breast cancer cells and is associated with ER? over-expression in breast cancer.
Neoplasms
An atlas of transposable element-derived alternative splicing in cancer.
Neoplasms
Bisphenol A and Phthalates Modulate Peritoneal Macrophage Function in Female Mice Involving SYMD2-H3K36 Dimethylation.
Neoplasms
Distinct roles of structure-specific endonucleases EEPD1 and Metnase in replication stress responses.
Neoplasms
Ectopic expression of wild-type FGFR3 cooperates with MYC to accelerate development of B-cell lineage neoplasms.
Neoplasms
Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
Neoplasms
Exome sequencing of bilateral testicular germ cell tumors suggests independent development lineages.
Neoplasms
Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells.
Neoplasms
Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
Neoplasms
Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.
Neoplasms
Histone methyltransferase MMSET/NSD2 alters EZH2 binding and reprograms the myeloma epigenome through global and focal changes in H3K36 and H3K27 methylation.
Neoplasms
Histone methyltransferase SETD2 inhibits tumor growth via suppressing CXCL1-mediated activation of cell cycle in lung adenocarcinoma.
Neoplasms
HIV?1 integrase inhibitors targeting various DDE transposases: Retroviral integration versus RAG?mediated recombination (Review).
Neoplasms
Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas.
Neoplasms
Identification of a peptide inhibitor for the histone methyltransferase WHSC1.
Neoplasms
Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
Neoplasms
Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer.
Neoplasms
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.
Neoplasms
Lung tumor-associated dendritic cell-derived resistin promoted cancer progression by increasing Wolf-Hirschhorn syndrome candidate 1/Twist pathway.
Neoplasms
Malignant hematological disorders in children with Wolf-Hirschhorn syndrome.
Neoplasms
Methylation of Aurora kinase A by MMSET reduces p53 stability and regulates cell proliferation and apoptosis.
Neoplasms
Metnase/SETMAR: a domesticated primate transposase that enhances DNA repair, replication, and decatenation.
Neoplasms
miR-34a, miR-424 and miR-513 inhibit MMSET expression to repress endometrial cancer cell invasion and sphere formation.
Neoplasms
MMSET is dynamically regulated during cell-cycle progression and promotes normal DNA replication.
Neoplasms
MMSET is highly expressed and associated with aggressiveness in neuroblastoma.
Neoplasms
MMSET is overexpressed in cancers: link with tumor aggressiveness.
Neoplasms
MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.
Neoplasms
MMSET/WHSC1 enhances DNA damage repair leading to an increase in resistance to chemotherapeutic agents.
Neoplasms
Multiple myeloma driving factor WHSC1 is a transcription target of oncogene HMGA2 that facilitates colon cancer proliferation and metastasis.
Neoplasms
Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.
Neoplasms
Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.
Neoplasms
Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.
Neoplasms
Neoamphimedine circumvents metnase-enhanced DNA topoisomerase II? activity through ATP-competitive inhibition.
Neoplasms
Nucleosome Binding Alters the Substrate Bonding Environment of Histone H3 Lysine 36 Methyltransferase NSD2.
Neoplasms
Overexpression of MMSET is Correlation with Poor Prognosis in Hepatocellular Carcinoma.
Neoplasms
Potential role for the Metnase transposase fusion gene in colon cancer through the regulation of key genes.
Neoplasms
PPAPDC1B and WHSC1L1 Are Common Drivers of the 8p11-12 Amplicon, Not Only in Breast Tumors But also in Pancreatic Adenocarcinomas and Lung Tumors.
Neoplasms
Prognostic significance of epigenetic regulatory gene expression in patients with non-small-cell lung cancer.
Neoplasms
Secondary genomic rearrangements involving immunoglobulin or MYC loci show similar prevalences in hyperdiploid and nonhyperdiploid myeloma tumors.
Neoplasms
Setd2 deficiency impairs hematopoietic stem cell self-renewal and causes malignant transformation.
Neoplasms
Targeted Next-Generation Sequencing Identifies Actionable Targets in Estrogen Receptor Positive and Estrogen Receptor Negative Endometriod Endometrial Cancer.
Neoplasms
Targeting the transposase domain of the DNA repair component Metnase to enhance chemotherapy.
Neoplasms
The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Neoplasms
The enigma of ectopic expression of FGFR3 in multiple myeloma: a critical initiating event or just a target for mutational activation during tumor progression.
Neoplasms
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Neoplasms
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer.
Neoplasms
The histone methyltransferase Wolf-Hirschhorn syndrome candidate 1-like 1 (WHSC1L1) is involved in human carcinogenesis.
Neoplasms
The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
Neoplasms
The SET and transposase domain protein Metnase enhances chromosome decatenation: regulation by automethylation.
Neoplasms
WHSC1 Promotes Cell Proliferation, Migration, and Invasion in Hepatocellular Carcinoma by Activating mTORC1 Signaling.
Neoplasms
WHSC1 promotes wnt/?-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
Neoplasms
WHSC1/NSD2 regulates immune infiltration in prostate cancer.
Neoplasms
WHSC1L1, on human chromosome 8p11.2, closely resembles WHSC1 and maps to a duplicated region shared with 4p16.3.
Neoplasms
Wolf-Hirschhorn Syndrome Candidate 1 (whsc1) Functions as a Tumor Suppressor by Governing Cell Differentiation.
Nephrosis
Wolf-Hirschhorn syndrome candidate 1-like 1 epigenetically regulates nephrin gene expression.
Neuroblastoma
MMSET is highly expressed and associated with aggressiveness in neuroblastoma.
Ovarian Neoplasms
E2F2 induces MCM4, CCNE2 and WHSC1 upregulation in ovarian cancer and predicts poor overall survival.
Prostatic Neoplasms
AKT-mediated stabilization of histone methyltransferase WHSC1 promotes prostate cancer metastasis.
Prostatic Neoplasms
Histone methyltransferase NSD2/MMSET mediates constitutive NF-?B signaling for cancer cell proliferation, survival, and tumor growth via a feed-forward loop.
Prostatic Neoplasms
Inhibition of WHSC1 Allows for Reprogramming of the Immune Compartment in Prostate Cancer.
Prostatic Neoplasms
Integrated Analysis of Genetic Abnormalities of the Histone Lysine Methyltransferases in Prostate Cancer.
Prostatic Neoplasms
Re: AKT-Mediated Stabilization of Histone Methyltransferase WHSC1 Promotes Prostate Cancer Metastasis.
Small Cell Lung Carcinoma
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Starvation
Regulation of Epigenetic Modifiers, Including KDM6B, by Interferon-? and Interleukin-4 in Human Macrophages.
Stomach Neoplasms
Differential effect of MMSET mRNA levels on survival to first-line FOLFOX and second-line docetaxel in gastric cancer.
Stomach Neoplasms
MiR-2392 suppresses metastasis and epithelial-mesenchymal transition by targeting MAML3 and WHSC1 in gastric cancer.
Urinary Bladder Neoplasms
The histone methyltransferase and putative oncoprotein MMSET is overexpressed in a large variety of human tumors.
Uterine Cervical Neoplasms
Epigenetic activation of WHSC1 functions as an oncogene and is associated with poor prognosis in cervical cancer.
Uterine Cervical Neoplasms
WHSC1 acts as a prognostic indicator and functions as an oncogene in cervical cancer.
Wolf-Hirschhorn Syndrome
109?kb deletion of chromosome 4p16.3 in a patient with mild phenotype of Wolf-Hirschhorn syndrome.
Wolf-Hirschhorn Syndrome
Auditory hair cell defects as potential cause for sensorineural deafness in Wolf-Hirschhorn syndrome.
Wolf-Hirschhorn Syndrome
De novo nonsense mutation in WHSC1 (NSD2) in patient with intellectual disability and dysmorphic features.
Wolf-Hirschhorn Syndrome
Deletions involving genes WHSC1 and LETM1 may be necessary, but are not sufficient to cause Wolf-Hirschhorn syndrome.
Wolf-Hirschhorn Syndrome
Developmental delay and failure to thrive associated with a loss-of-function variant in WHSC1 (NSD2).
Wolf-Hirschhorn Syndrome
Dissecting the Wolf-Hirschhorn syndrome phenotype: WHSC1 is a neurodevelopmental gene contributing to growth delay, intellectual disability, and to the facial dysmorphism.
Wolf-Hirschhorn Syndrome
Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2.
Wolf-Hirschhorn Syndrome
H3K36 dimethylation by MMSET promotes classical non-homologous end-joining at unprotected telomeres.
Wolf-Hirschhorn Syndrome
Identification of miR-2400 gene as a novel regulator in skeletal muscle satellite cells proliferation by targeting MYOG gene.
Wolf-Hirschhorn Syndrome
Interstitial microdeletion of 4p16.3: contribution of WHSC1 haploinsufficiency to the pathogenesis of developmental delay in Wolf-Hirschhorn syndrome.
Wolf-Hirschhorn Syndrome
MMSET is overexpressed in cancers: link with tumor aggressiveness.
Wolf-Hirschhorn Syndrome
NSD3, a new SET domain-containing gene, maps to 8p12 and is amplified in human breast cancer cell lines.
Wolf-Hirschhorn Syndrome
Partial Monosomy 4p and Trisomy 12q due to a t(4;12)(p16.3;q24.31) Familial Translocation in Two Cousins.
Wolf-Hirschhorn Syndrome
The PWWP domain: a potential protein-protein interaction domain in nuclear proteins influencing differentiation?
Wolf-Hirschhorn Syndrome
WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma.
Wolf-Hirschhorn Syndrome
Wolf-Hirschhorn syndrome candidate 1 is involved in the cellular response to DNA damage.
Wolf-Hirschhorn Syndrome
[Prenatal diagnosis of a case with 46,XX,del(4),dup(21)].
[histone h3]-lysine36 n-dimethyltransferase deficiency
The histone methyltransferase MMSET regulates class switch recombination.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Eram, M.S.; Kuznetsova, E.; Li, F.; Lima-Fernandes, E.; Kennedy, S.; Chau, I.; Arrowsmith, C.H.; Schapira, M.; Vedadi, M.
Kinetic characterization of human histone H3 lysine 36 methyltransferases, ASH1L and SETD2
Biochim. Biophys. Acta
1850
1842-1848
2015
Homo sapiens (Q9NR48)
brenda
Rogawski, D.; Grembecka, J.; Cierpicki, T.
H3K36 methyltransferases as cancer drug targets Rationale and perspectives for inhibitor development
Future Med. Chem.
8
1589-1607
2016
Homo sapiens, Homo sapiens (Q96L73), Homo sapiens (Q9NR48)
-
brenda
Poulin, M.; Schneck, J.; Matico, R.; Hou, W.; McDevitt, P.; Holbert, M.; Schramm, V.
Nucleosome binding alters the substrate bonding environment of histone H3 lysine 36 methyltransferase NSD2
J. Am. Chem. Soc.
138
6699-6702
2016
Homo sapiens (Q96028)
brenda
Qiao, Q.; Li, Y.; Chen, Z.; Wang, M.; Reinberg, D.; Xu, R.
The structure of NSD1 reveals an autoregulatory mechanism underlying histone H3K36 methylation
J. Biol. Chem.
286
8361-8368
2011
Homo sapiens (Q96L73)
brenda
Wagner, E.; Carpenter, P.
Understanding the language of Lys36 methylation at histone H3
Nat. Rev. Mol. Cell Biol.
13
115-126
2012
Homo sapiens
brenda
Fnu, S.; Williamson, E.; De Haro, L.; Brenneman, M.; Wray, J.; Shaheen, M.; Radhakrishnan, K.; Lee, S.; Nickoloff, J.; Hromasa, R.
Methylation of histone H3 lysine 36 enhances DNA repair by nonhomologous end-joining
Proc. Natl. Acad. Sci. USA
108
551-556
2011
Homo sapiens (Q53H47), Homo sapiens
brenda
Poulin, M.; Schneck, J.; Matico, R.; McDevitt, P.; Huddleston, M.; Hou, W.; Johnson, N.; Thrall, S.; Meek, T.; Schramm, V.
Transition state for the NSD2-catalyzed methylation of histone H3 lysine 36
Proc. Natl. Acad. Sci. USA
113
1197-1201
2016
Homo sapiens (O96028)
brenda
Fang, D.; Gan, H.; Lee, J.; Han, J.; Wang, Z.; Riester, S.; Jin, L.; Chen, J.; Zhou, H.; Wang, J.; Zhang, H.; Yang, N.; Bradley, E.; Ho, T.; Rubin, B.; Bridge, J.; Thibodeau, S.; Ordog, T.; Chen, Y.; Van Wijnen, A.; Oliveira, A.; Xu, R.; Westendorf, J.
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas
Science
352
1344-1348
2016
Homo sapiens
brenda
Morishita, M.; Di Luccio, E.
Structural insights into the regulation and the recognition of histone marks by the SET domain of NSD1
Biochem. Biophys. Res. Commun.
412
214-219
2011
Homo sapiens (Q96L73)
brenda
Morishita, M.; Mevius, D.; Di Luccio, E.
In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L
BMC Struct. Biol.
14
25
2014
Homo sapiens (Q96L73)
brenda
Shen, Y.; Morishita, M.; di Luccio, E.
High yield recombinant expression and purification of oncogenic NSD1, NSD2, and NSD3 with human influenza hemagglutinin tag
Protein Expr. Purif.
166
105506
2020
Homo sapiens (Q96L73)
brenda